130 related articles for article (PubMed ID: 8824565)
21. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis.
Huo TI; Wang XW; Forgues M; Wu CG; Spillare EA; Giannini C; Brechot C; Harris CC
Oncogene; 2001 Jun; 20(28):3620-8. PubMed ID: 11439325
[TBL] [Abstract][Full Text] [Related]
22. Tumour suppressor p53 and Rb genes in human hepatocellular carcinoma.
Lin Y; Shi CY; Li B; Soo BH; Mohammed-Ali S; Wee A; Oon CJ; Mack PO; Chan SH
Ann Acad Med Singap; 1996 Jan; 25(1):22-30. PubMed ID: 8779541
[TBL] [Abstract][Full Text] [Related]
23. The point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province, a non HCC prevalent area in China.
Liu H; Wang Y; Zhou Q; Gui SY; Li X
World J Gastroenterol; 2002 Jun; 8(3):480-2. PubMed ID: 12046074
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.
Kew MC
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():144-52. PubMed ID: 21199526
[TBL] [Abstract][Full Text] [Related]
25. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B viral transactivator HBx alleviates p53-mediated repression of alpha-fetoprotein gene expression.
Ogden SK; Lee KC; Barton MC
J Biol Chem; 2000 Sep; 275(36):27806-14. PubMed ID: 10842185
[TBL] [Abstract][Full Text] [Related]
27. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma.
Yeh CT; Shen CH; Tai DI; Chu CM; Liaw YF
Oncogene; 2000 Nov; 19(46):5213-20. PubMed ID: 11077437
[TBL] [Abstract][Full Text] [Related]
28. Involvement of hepatitis B virus X gene (HBx) integration in hepatocarcinogenesis via a recombination of HBx/Alu core sequence/subtelomeric DNA.
Zhang X; You X; Li N; Zhang W; Gagos S; Wang Q; Banos A; Cai N; Zhang H; Zhang H; Zhang X; Shan C; Qiu L; Zhang S; Lv N; Chen M; Du Y; Xia J; Ye L; Zhang X
FEBS Lett; 2012 Sep; 586(19):3215-21. PubMed ID: 22771476
[TBL] [Abstract][Full Text] [Related]
29. HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma.
Qiu X; Dong S; Qiao F; Lu S; Song Y; Lao Y; Li Y; Zeng T; Hu J; Zhang L; Zhang L; Fan H
Oncogene; 2013 Jul; 32(27):3296-305. PubMed ID: 23604124
[TBL] [Abstract][Full Text] [Related]
30. Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations.
Rashid A; Wang JS; Qian GS; Lu BX; Hamilton SR; Groopman JD
Br J Cancer; 1999 Apr; 80(1-2):59-66. PubMed ID: 10389978
[TBL] [Abstract][Full Text] [Related]
31. Analysis of hepatitis B virus X gene (HBx) mutants in tissues of patients suffered from hepatocellular carcinoma in China.
Wang Q; Zhang T; Ye L; Wang W; Zhang X
Cancer Epidemiol; 2012 Aug; 36(4):369-74. PubMed ID: 22178505
[TBL] [Abstract][Full Text] [Related]
32. Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma.
Yumoto Y; Hanafusa T; Hada H; Morita T; Ooguchi S; Shinji N; Mitani T; Hamaya K; Koide N; Tsuji T
J Gastroenterol Hepatol; 1995; 10(2):179-85. PubMed ID: 7540433
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus X protein induced expression of the Nur77 gene.
Lee MO; Kang HJ; Cho H; Shin EC; Park JH; Kim SJ
Biochem Biophys Res Commun; 2001 Nov; 288(5):1162-8. PubMed ID: 11700033
[TBL] [Abstract][Full Text] [Related]
34. Functional inactivation but not structural mutation of p53 causes liver cancer.
Ueda H; Ullrich SJ; Gangemi JD; Kappel CA; Ngo L; Feitelson MA; Jay G
Nat Genet; 1995 Jan; 9(1):41-7. PubMed ID: 7704023
[TBL] [Abstract][Full Text] [Related]
35. [Identification of HBx-related integration sites in HBsAg-positive hepatocellular carcinoma biopsy].
Zhu BH; Wang LT; Li T; Zhou BP
Zhonghua Gan Zang Bing Za Zhi; 2012 Jun; 20(6):468-71. PubMed ID: 23044207
[TBL] [Abstract][Full Text] [Related]
36. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues.
Tu H; Bonura C; Giannini C; Mouly H; Soussan P; Kew M; Paterlini-Bréchot P; Bréchot C; Kremsdorf D
Cancer Res; 2001 Nov; 61(21):7803-10. PubMed ID: 11691796
[TBL] [Abstract][Full Text] [Related]
37. [Analysis of cell origin of human hepatocellular carcinoma according to p53 gene mutation].
He B; Tang Z; Liu K
Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):335-8. PubMed ID: 9387269
[TBL] [Abstract][Full Text] [Related]
38. p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis.
Teramoto T; Satonaka K; Kitazawa S; Fujimori T; Hayashi K; Maeda S
Cancer Res; 1994 Jan; 54(1):231-5. PubMed ID: 8261444
[TBL] [Abstract][Full Text] [Related]
39. TP53 and hepatocellular carcinoma.
Puisieux A; Ozturk M
Pathol Biol (Paris); 1997 Dec; 45(10):864-70. PubMed ID: 9769950
[TBL] [Abstract][Full Text] [Related]
40. P53 mutations in hepatocellular carcinoma patients in Egypt.
El-Kafrawy SA; Abdel-Hamid M; El-Daly M; Nada O; Ismail A; Ezzat S; Abdel-Latif S; Abdel-Hamid A; Shields PG; Loffredo C
Int J Hyg Environ Health; 2005; 208(4):263-70. PubMed ID: 16078640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
